Sector ratings Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Equities

End-of-day quote Shanghai S.E. Other stock markets 22/01/2026			5-day change	1st Jan Change
59.44 ^CNY	-1.10%		-6.56%	-0.22%

01-13	Hengrui Pharma Unit Secures Approval to Conduct Clinical Trial for Hypertension Drug	MT
01-13	Hengrui Pharma's Cancer Drug Obtains China Breakthrough Therapy Designation	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	57.39B		AA
ELI LILLY AND COMPANY	966B		A
JOHNSON & JOHNSON	525B		BBB
ABBVIE INC.	382B		AA
ROCHE HOLDING AG	371B		AA
ASTRAZENECA PLC	278B		A
NOVARTIS AG	276B		AAA
MERCK & CO., INC.	276B		A
NOVO NORDISK A/S	260B		A
AMGEN INC.	185B		A
GILEAD SCIENCES, INC.	160B		AAA
PFIZER INC.	147B		BBB
VERTEX PHARMACEUTICALS INCORPORATED	117B		AA
BRISTOL-MYERS SQUIBB COMPANY	111B		A
SANOFI	111B		A
GSK PLC	96.35B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	86.54B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
TAKEDA PHARMACEUTICAL COMPANY LIMITED	49.69B		AA
BAYER AG	49.05B		AA
Average	228.4B		AA
Weighted average by Cap.			AA